An overview of some potential immunotherapeutic options against COVID-19

After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despite relentless efforts to control the disease by drug repurposing, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayat, Maryam, Asemani, Yahya, Mohammadi, Mohammad Reza, Sanaei, Mahsa, Namvarpour, Mozhdeh, Eftekhari, Reyhaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908848/
https://www.ncbi.nlm.nih.gov/pubmed/33765610
http://dx.doi.org/10.1016/j.intimp.2021.107516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908848/
https://www.ncbi.nlm.nih.gov/pubmed/33765610
http://dx.doi.org/10.1016/j.intimp.2021.107516

Ejemplares similares